These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 29778432

  • 1. The effect of exposure to sub-inhibitory concentrations of hypochlorite and quaternary ammonium compounds on antimicrobial susceptibility of Pseudomonas aeruginosa.
    Nasr AM, Mostafa MS, Arnaout HH, Elshimy AAA.
    Am J Infect Control; 2018 Jul; 46(7):e57-e63. PubMed ID: 29778432
    [Abstract] [Full Text] [Related]

  • 2. Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States.
    Sader HS, Huband MD, Castanheira M, Flamm RK.
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069652
    [Abstract] [Full Text] [Related]

  • 3. Hydrogen peroxide and sodium hypochlorite disinfectants are more effective against Staphylococcus aureus and Pseudomonas aeruginosa biofilms than quaternary ammonium compounds.
    Lineback CB, Nkemngong CA, Wu ST, Li X, Teska PJ, Oliver HF.
    Antimicrob Resist Infect Control; 2018 Mar; 7():154. PubMed ID: 30568790
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran.
    Shahri FN, Izanloo A, Goharrizi MASB, Jamali A, Bagheri H, Hjimohammadi A, Ardebili A.
    Int Microbiol; 2022 Nov; 25(4):709-721. PubMed ID: 35697891
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals: CANWARD 2008-2011.
    Walkty A, Baxter M, Adam H, Karlowsky JA, Lagacé-Wiens P, Hoban DJ, Zhanel GG.
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):361-4. PubMed ID: 22694789
    [Abstract] [Full Text] [Related]

  • 6. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M, Carbonnelle S, Avrain L, Mesaros N, Pirnay JP, Bilocq F, De Vos D, Simon A, Piérard D, Jacobs F, Dediste A, Tulkens PM, Van Bambeke F, Glupczynski Y.
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [Abstract] [Full Text] [Related]

  • 7. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
    Jones RN, Kirby JT, Beach ML, Biedenbach DJ, Pfaller MA.
    Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mutant selection window of disinfectants for Staphylococcus aureus and Pseudomonas aeruginosa.
    Kawamura M, Fujimura S, Tokuda K, Aoyagi T, Endo S, Kanamori H, Watanabe A, Kaku M.
    J Glob Antimicrob Resist; 2019 Jun; 17():316-320. PubMed ID: 30684653
    [Abstract] [Full Text] [Related]

  • 10. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
    Nazli E, Zer Y, Eksi F.
    J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417
    [Abstract] [Full Text] [Related]

  • 11. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A, Adukauskiene D, Jeroch J, Vitkauskiene A.
    Medicina (Kaunas); 2009 Apr; 45(1):1-7. PubMed ID: 19223699
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of in vitro synergistic antibiotic interaction between fosfomycin and nonsusceptible antimicrobials in carbapenem-resistant Pseudomonas aeruginosa.
    Avery LM, Sutherland CA, Nicolau DP.
    J Med Microbiol; 2019 Jun; 68(6):893-897. PubMed ID: 31050629
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of sodium hypochlorite against multidrug-resistant Gram-negative bacteria.
    Köhler AT, Rodloff AC, Labahn M, Reinhardt M, Truyen U, Speck S.
    J Hosp Infect; 2018 Nov; 100(3):e40-e46. PubMed ID: 30026008
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of adaptation process of Pseudomonas aeruginosa to didecyldimethylammonium chloride in 2-propanol on bactericidal efficiency of this active substance.
    Chojecka A, Wiercińska O, Röhm-Rodowald E, Kanclerski K, Jakimiak B.
    Rocz Panstw Zakl Hig; 2014 Nov; 65(4):359-64. PubMed ID: 25526583
    [Abstract] [Full Text] [Related]

  • 16. Integrating pharmacokinetics, pharmacodynamics and MIC distributions to assess changing antimicrobial activity against clinical isolates of Pseudomonas aeruginosa causing infections in Canadian hospitals (CANWARD).
    Zelenitsky SA, Rubinstein E, Ariano RE, Zhanel GG, Canadian Antimicrobial Resistance Alliance.
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i67-72. PubMed ID: 23587780
    [Abstract] [Full Text] [Related]

  • 17. In Vitro Comparison of Ceftolozane-Tazobactam to Traditional Beta-Lactams and Ceftolozane-Tazobactam as an Alternative to Combination Antimicrobial Therapy for Pseudomonas aeruginosa.
    Goodlet KJ, Nicolau DP, Nailor MD.
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
    [Abstract] [Full Text] [Related]

  • 18. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F, Akhtar N, Hameed A.
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [Abstract] [Full Text] [Related]

  • 19. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
    Henderson A, Tan E, McCarthy KL, Paterson DL.
    Pathology; 2018 Dec; 50(7):748-752. PubMed ID: 30392710
    [Abstract] [Full Text] [Related]

  • 20. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
    Millar BC, Rendall JC, Downey DG, Moore JE.
    J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.